IMPT Vs. VMAT: A Treatment Planning Study for High-Risk Prostate Cancer

被引：0
|
作者：
Rana, S. [1 ]
Zheng, Y. [1 ]
Cheng, C. [2 ]
机构：
[1] ProCure Proton Therapy Ctr, Oklahoma City, OK USA
[2] Vantage Oncol, West Hills, CA USA
来源：
MEDICAL PHYSICS | 2015年 / 42卷 / 06期
关键词：
D O I：
10.1118/1.4924839
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：3444 / 3444
页数：1
相关论文
共 50 条
  • [31] Current controversies in the treatment of high-risk prostate cancer
    Mitchell, Robert E.
    Chang, Sam S.
    CURRENT OPINION IN UROLOGY, 2008, 18 (03) : 263 - 268
  • [32] Optimal Treatment for High-Risk Prostate Cancer Reply
    Kishan, Atnar U.
    Cook, Ryan R.
    King, Christopher R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (04): : 405 - 405
  • [33] Adjuvant therapy with antiandrogens vs. gonadotropin releasing hormone agonists combined with radiotherapy and risk of prostate cancer death in men with high-risk prostate cancer
    Miranda, Bonde T.
    Swanberg, D.
    Gunnlaugsson, A.
    Nilsson, P.
    Garmo, H.
    Stattin, P.
    Robinson, D.
    EUROPEAN UROLOGY, 2023, 83
  • [34] Intensity modulated proton therapy (IMPT) vs. helicoidal tomotherapy (HT) in the treatment of nasopharynx cancer: A planning comparison
    Widesott, L.
    Pierelli, A.
    Fiorino, C.
    Dell'Oca, I.
    Cattaneo, G.
    Alber, M.
    Solikup, M.
    Fazio, F.
    Calandrino, R.
    Schwarz, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S663 - S663
  • [35] A dosimetric comparison of Helical Tomotherapy and VMAT in the treatment of high risk prostate cancer
    Lacornerie, T.
    Cavillon, F.
    Hardhuin, R.
    Compte, P.
    Reynaert, N.
    Lartigau, E. F.
    Pasquier, D.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S202 - S202
  • [36] Dynamic Conformal Arcs Vs. VMAT for Stereotactic Lung Target Treatment Planning
    Hershberger, J.
    Morales, M.
    Ding, G.
    MEDICAL PHYSICS, 2014, 41 (06) : 254 - 254
  • [37] Boost treatment for intermediate and high risk prostate cancer: low dose rate vs. high dose rate
    Ivker, RA
    Helfman, AS
    Shoengold, S
    Strumeyer, AD
    Varsos, G
    Coia, LR
    Chen, W
    Bell, L
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S5 - S5
  • [38] Dependence of Collimator Angle on Prostate VMAT: A Treatment Planning Study
    Isa, Muhammad
    Rehman, Jalil Ur
    Afzal, Muhammad
    Chow, James C. L.
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, 2015, VOLS 1 AND 2, 2015, 51 : 384 - 387
  • [39] High-risk prostate cancer: treat the prostate
    Cooperberg, Matthew R.
    LANCET, 2011, 378 (9809): : 2056 - 2057
  • [40] MRI vs. mammography in high-risk patients
    Ebell, M
    AMERICAN FAMILY PHYSICIAN, 2004, 70 (11) : 2202 - 2203
12345